These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 4801897)

  • 1. Wilson's disease: modification by L-DOPA.
    Gelmers HJ; Troost J; Willemse J
    Neuropadiatrie; 1973 Dec; 4(4):453-7. PubMed ID: 4801897
    [No Abstract]   [Full Text] [Related]  

  • 2. Copper chelation in patients with Wilson's disease. A comparison of penicillamine and triethylene tetramine dihydrochloride.
    Walshe JM
    Q J Med; 1973 Jul; 42(167):441-52. PubMed ID: 4728043
    [No Abstract]   [Full Text] [Related]  

  • 3. The pattern of urinary copper excretion and its response to treatment in patients with Wilson's disease.
    Walshe JM
    QJM; 2011 Sep; 104(9):775-8. PubMed ID: 21622540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Favorable results with an association of L-dopa and amantadine added to penicillamine in the treatment of Wilson's disease].
    Berio A; Vento R; Di Stefano A
    Minerva Pediatr; 1973 May; 25(18):807-13. PubMed ID: 4732090
    [No Abstract]   [Full Text] [Related]  

  • 5. Hypothyroidism and dyshormonogenesis induced by D-penicillamine in children with Wilson's disease and healthy infants born to a mother with Wilson's disease.
    Hanukoglu A; Curiel B; Berkowitz D; Levine A; Sack J; Lorberboym M
    J Pediatr; 2008 Dec; 153(6):864-6. PubMed ID: 19014823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pathogenesis and treatment of Wilson's disease].
    Nagy J; Vincze Z; Folhoffer A; Horváth A; Csák T; Zelkó R
    Acta Pharm Hung; 2003; 73(4):237-41. PubMed ID: 15279036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of Wilson's disease with L-dopa after failure with penicillamine.
    Barbeau A; Friesen H
    Lancet; 1970 May; 1(7657):1180-1. PubMed ID: 4192136
    [No Abstract]   [Full Text] [Related]  

  • 8. [Urine copper determination in Wilson's disease during therapy].
    Schnack H
    Wien Z Inn Med; 1967; 48(12):469-76. PubMed ID: 5620588
    [No Abstract]   [Full Text] [Related]  

  • 9. [Experiences with penicillamine in Wilson's disease].
    Lössner J; Bachmann H; Eichner B
    Psychiatr Neurol Med Psychol Beih; 1975; 20-21():48-53. PubMed ID: 829635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of Wilson's disease].
    Pépin B; Barraine R
    Cah Coll Med Hop Paris; 1968 Feb; 9(2):184-7. PubMed ID: 5745277
    [No Abstract]   [Full Text] [Related]  

  • 11. Metabolic studies in Wilson's disease. Evaluation of efficacy of chelation therapy in respect to copper balance.
    Strickland GT; Blackwell RQ; Watten RH
    Am J Med; 1971 Jul; 51(1):31-40. PubMed ID: 5570318
    [No Abstract]   [Full Text] [Related]  

  • 12. [Biochemical bases and therapeutic possibilities of K. Wilson's hepatolenticular degeneration].
    Grau-Veciana JM; Barraquer-Bordas L
    Arch Neurobiol (Madr); 1967; 30(3):251-74. PubMed ID: 4970136
    [No Abstract]   [Full Text] [Related]  

  • 13. Iron accumulation in the liver of male patients with Wilson's disease.
    Shiono Y; Wakusawa S; Hayashi H; Takikawa T; Yano M; Okada T; Mabuchi H; Kono S; Miyajima H
    Am J Gastroenterol; 2001 Nov; 96(11):3147-51. PubMed ID: 11721763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Checking of urinary copper in patients with Wilson's disease during treatment with D-penicillamine].
    Indaco A; Pellegrino L; Campanella G
    Acta Neurol Quad (Napoli); 1979; 39():160-4. PubMed ID: 555232
    [No Abstract]   [Full Text] [Related]  

  • 15. Ineffectiveness of L-dopa as supplement to penicillamine in a case of Wilson's disease.
    Morgan JP; Preziosi TJ; Bianchine JR
    Lancet; 1970 Sep; 2(7674):659. PubMed ID: 4195789
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of penicillamine and zinc on iron metabolism in Wilson's disease.
    Medici V; Di Leo V; Lamboglia F; Bowlus CL; Tseng SC; D'Incà R; Irato P; Burra P; Martines D; Sturniolo GC
    Scand J Gastroenterol; 2007 Dec; 42(12):1495-500. PubMed ID: 17994470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient with late-onset Wilson's disease: deterioration with penicillamine.
    Sohtaoglu M; Ergin H; Ozekmekçi S; Gökdemir S; Sonsuz A; Arici C
    Mov Disord; 2007 Jan; 22(2):290-1. PubMed ID: 17083099
    [No Abstract]   [Full Text] [Related]  

  • 18. Wilson's disease and pregnancy.
    Sternlieb I
    Hepatology; 2000 Feb; 31(2):531-2. PubMed ID: 10655282
    [No Abstract]   [Full Text] [Related]  

  • 19. Brief observations on the management of Wilson's disease.
    Walshe JM
    Proc R Soc Med; 1977; 70 Suppl 3(Suppl 3):1-3. PubMed ID: 122651
    [No Abstract]   [Full Text] [Related]  

  • 20. Early onset of nephrotic syndrome after treatment with D-penicillamine in a patient with Wilson's disease.
    Siafakas CG; Jonas MM; Alexander S; Herrin J; Furuta GT
    Am J Gastroenterol; 1998 Dec; 93(12):2544-6. PubMed ID: 9860423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.